株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

子宮頸癌の主要22カ国市場の予測:2016-2026年

Epiomic Epidemiology Series: Cervical Cancer Forecast in 22 Major Markets 2016-2026

発行 Black Swan Analysis 商品コード 378994
出版日 ページ情報 英文 50 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.74円で換算しております。
子宮頸癌の主要22カ国市場の予測:2016-2026年 Epiomic Epidemiology Series: Cervical Cancer Forecast in 22 Major Markets 2016-2026
出版日: 2016年10月01日 ページ情報: 英文 50 Pages
概要

当レポートでは、世界の主要22カ国市場における子宮頸癌の罹患状況を調査し、有病数の推移と予測、性別・ステージ・組織病理学的タイプなど各種区分別の内訳、疾患の概要、危険因子、疾患の診断と予後、主な症状や併存症などをまとめています。

調査対象国

  • 米国
  • カナダ
  • フランス
  • ドイツ
  • イタリア
  • スぺイン
  • 英国
  • オランダ
  • ポーランド
  • ルーマニア
  • ロシア
  • トルコ
  • オーストラリア
  • 日本
  • 韓国
  • 中国
  • インド
  • アルゼンチン
  • ブラジル
  • メキシコ
  • 南アフリカ
  • サウジアラビア

目次

  • イントロダクション
  • 病因
  • 危険因子と予防
  • 疾患の診断
  • 地域/民族による違い
  • 疾患予後と臨床経過
  • 疾患に関連する主な併存症/特徴
  • 患者数を定量化する手法
  • 子宮癌の有病者数
  • 子宮癌のステージ
  • 組織病理
  • 略語
  • 関連出版物
  • オンラインデータベース
  • 参考文献
  • 付録
目次
Product Code: CXUT0011016

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Cervical Cancer in 22 Major Markets

Cervical cancer (ICD-10 code C53, cervix uteri) is a type of cancer that occurs in the cells of the cervix. Cervical cancer is generally preceded by Cervical Intraepithelial Neoplasia (CIN).

Nearly all cervical cancer cases (>90%) have been linked with HPV infection, with identification of 14 high-risk HPV (hrHPV) genotypes linked to cervical cancer.

Typically, squamous cells lining the cervix respond to exposure to HPV infection, causing them to replicate. The extent of abnormal growth (in the pre-cancerous phase) is the basis for CIN grading, from 1 to 3, where 3 represents disorganisation through the full extent of then epithelial layer.

This report provides the current incident population for Cervical Cancer across 22 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Netherlands, Poland, Romania, Russia, Turkey, Australia, Japan, South Korea, China, India, Argentina, Brazil, Mexico, South Africa and Saudi Arabia) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Cervical Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

The following conditions are associated with cervical cancer:

  • Infection with HPV genotypes 16 & 18
  • Unprotected sex
  • Extended use of oral contraceptives
  • Impaired immunity
  • Smoking

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Cervical Cancer market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the incidence of the subdivided types of Cervical Cancer and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Cervical Cancer's Incident population.
  • Identify sub-populations within Cervical Cancer which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Cervical Cancer patients.

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key comorbid conditions/Features associated with the disease
  • Methodology for quantification of patient numbers
    • Impact of HPV vaccination
    • Additional data available on request
  • Top-line prevalence for Cervical Cancer
  • Stage of Cervical Cancer patients
  • Histopathology of Cervical Cancer patients
  • Abbreviations used in the report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix

List of Tables

  • HPV type and disease association with cervical cancer
  • HPV vaccines currently available
  • The Bethesda Classification System for cervical squamous cell dysplasia
  • FIGO staging of cervical cancer
  • 5-year survival rate by stage of cervical cancer
  • Incidence of Cervical cancer, females (000s)
  • Cervical cancer patients by FIGO stage, females (000s)
  • Cervical cancer patients by histopathologic type, females (000s)
  • Abbreviations and Acronyms used in the report
  • USA Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • Canada Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • France Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • Germany Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • Italy Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • Spain Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • United Kingdom Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • Netherlands Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • Poland Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • Romania Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • Russia Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • Turkey Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • Australia Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • Japan Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • South Korea Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • China Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • India Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • Argentina Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • Brazil Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • Mexico Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • South Africa Incidence of Cervical Cancer by 5-yr age cohort, females (000s)
  • Saudi Arabia Incidence of Cervical Cancer by 5-yr age cohort, females (000s)

List of Figures

  • Profiles of Cervical cancer incidence by age
  • Incidence of Cervical cancer by country
  • Expected impact in Cervical cancer incidence due to HPV immunisation (UK)